Free Trial

Altamira Therapeutics (CYTO) SEC Filings & 10K Form

Altamira Therapeutics logo
$0.42 -0.01 (-3.39%)
(As of 02:58 PM ET)

Recent Altamira Therapeutics SEC Filings

DateFilerForm TypeView
10/04/2024
3:01 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
7:15 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:19 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 424B4
09/17/2024
11:15 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form EFFECT
09/16/2024
12:55 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form F-1/A
09/16/2024
8:29 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form F-1/A
08/22/2024
3:53 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
07/14/2024
11:15 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form EFFECT
07/08/2024
4:17 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form POS AM
07/01/2024
6:08 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 20-F/A
04/22/2024
3:31 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 20-F/A
04/17/2024
11:15 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form EFFECT
04/17/2024
3:20 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 424B4
04/16/2024
4:00 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2024
7:30 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2024
7:30 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2024
7:00 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/10/2024
7:15 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
04/10/2024
7:15 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2024
10:03 AM
Altamira Therapeutics Ltd. (Subject)
Altamira Therapeutics (Subject)
Meyer Thomas (Filed by)
Form SC 13D/A
01/22/2024
4:02 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 424B4
01/21/2024
11:15 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form EFFECT
01/19/2024
3:40 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 424B5
01/19/2024
3:45 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/19/2024
3:30 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
4:02 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/11/2023
7:00 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2023
7:01 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/08/2023
8:00 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2023
3:30 PM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
7:00 AM
Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CYTO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners